| An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development DM van Pel, IJ Barrett, Y Shimizu, BV Sajesh, BJ Guppy, T Pfeifer, ... PLoS genetics 9 (1), e1003254, 2013 | 111 | 2013 |
| Synthetic lethality of cohesins with PARPs and replication fork mediators JL McLellan, NJ O'Neil, I Barrett, E Ferree, DM van Pel, K Ushey, ... PLoS genetics 8 (3), e1002574, 2012 | 90 | 2012 |
| Glioblastoma Cells Containing Mutations in the Cohesin Component STAG2 Are Sensitive to PARP Inhibition ML Bailey, NJ O'Neil, DM van Pel, DA Solomon, T Waldman, P Hieter Molecular cancer therapeutics 13 (3), 724-732, 2014 | 89 | 2014 |
| Modelling glioma invasion using 3D bioprinting and scaffold-free 3D culture DM van Pel, K Harada, D Song, CC Naus, WC Sin Journal of cell communication and signaling 12, 723-730, 2018 | 59 | 2018 |
| Synthetic lethality and cancer: cohesin and PARP at the replication fork NJ O’Neil, DM van Pel, P Hieter Trends in genetics 29 (5), 290-297, 2013 | 47 | 2013 |
| Saccharomyces cerevisiae Genetics Predicts Candidate Therapeutic Genetic Interactions at the Mammalian Replication Fork DM van Pel, PC Stirling, SW Minaker, P Sipahimalani, P Hieter G3: Genes| Genomes| Genetics 3 (2), 273-282, 2013 | 44 | 2013 |
| Modeling analyte permeation in cylindrical hollow fiber membrane introduction mass spectrometry DW Janes, CJ Durning, DM van Pel, MS Lynch, CG Gill, ET Krogh Journal of Membrane Science 325 (1), 81-91, 2008 | 21 | 2008 |
| The MADD-3 LAMMER Kinase Interacts with a p38 MAP Kinase Pathway to Regulate the Display of the EVA-1 Guidance Receptor in Caenorhabditis elegans SA D’Souza, L Rajendran, R Bagg, L Barbier, DM van Pel, H Moshiri, ... PLoS Genetics 12 (4), e1006010, 2016 | 9 | 2016 |
| Membrane introduction tandem mass spectrometry (MIMS-MS/MS) as a real-time monitor for biogenic volatile organic compound (BVOC) emissions from plants AJ Thompson, JM Etzkorn, DM van Pel, ET Krogh, DR Drakeford, CG Gill Canadian Journal of Analytical Sciences and Spectroscopy 53 (2), 75-81, 2008 | 8 | 2008 |
| Distinct Uroplakin II staining pattern in Apocrine breast carcinoma DM van Pel, J Pors, E Yuen, R Chan, Z Kos, MM Hayes, G Wang Applied Immunohistochemistry & Molecular Morphology 30 (10), 681-686, 2022 | 2 | 2022 |
| Proof‐of‐Concept in a 3D Culture Model of Glioma Invasion: Towards Personalized Therapeutics in Brain Cancer DM van Pel, CC Naus, WC Sin The FASEB Journal 32, 805.15-805.15, 2018 | 2 | 2018 |
| Measurement of environmentally relevant partition and diffusion coefficients using membrane introduction mass spectrometry ET Krogh, DM van Pel, MS Lynch, CG Gill, CJ Durning, D Janes 54 th ASMS Conference Proceedings, 2006 | 1 | 2006 |
| Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma DM van Pel, S Cheung, DN Ionescu, A Churg Human Pathology 141, 64-68, 2023 | | 2023 |
| Abstract IA7: Chromosome instability and synthetic lethality in yeast and cancer P Hieter, M Bailey, N O'Neil, D Pel, P Stirling Molecular Cancer Therapeutics 12 (5_Supplement), IA7-IA7, 2013 | | 2013 |
| Abstract B16: Cells containing mutations in the cohesin component, STAG2, are sensitive to PARP inhibition ML Bailey, NJ O'Neil, DM Pel, P Hieter Molecular Cancer Therapeutics 12 (5_Supplement), B16-B16, 2013 | | 2013 |
| Evolutionarily conserved synthetic lethal interaction networks reveal targets for anticancer therapeutic development DM van Pel University of British Columbia, 2012 | | 2012 |
| [Pre-print] Modeling analyte permeation in cylindrical hollow fiber membrane introduction mass spectrometry DW Janes, CJ Durning, DM van Pel, MS Lynch, CG Gill, ET Krogh Elsevier, 2008 | | 2008 |
| Modeling of Hollow Fiber Membrane Inlet Mass Spectrometry CJ Durning, D Janes, E Krogh, C Gill, D Van Pel The 2007 Annual Meeting, 2007 | | 2007 |
| Modeling of hollow fiber membrane inlet mass spectrometry DW Janes, CJ Durning, DM Van Pel, MS Lynch, ET Krogh, CG Gill 2007 AIChE Annual Meeting, 2007 | | 2007 |
Philip HieterProfessorVerified email at msl.ubc.ca
